neffy® nasal spray– emergency epi without a needle

Send us Fan Mail Summary:  neffy® nasal spray received fast track approval from the FDA on August 9, 2024 for the emergency treatment of type I allergic reactions, including anaphylaxis, in adult and pediatric patients who weight at least 66 pounds.  This may be a gamechanger in that it provides emergency epinephrine treatment for anaphylaxis without needles.  But, as with all medications, correct use and monitoring is necessary.  Topics·       Fast Track Approval 01:30·       $$$                          03:15·        Minimum Weight 66 pounds 04:15·       Approval Process 06:00·       Pharmacokinetics & Pharmacodynamics 07:00·       Epi Mechanism of Action 08:00·       How to use neffy 10:45·       Storage 13:00·       Gamechanger? 15:00·       risk – BENEFIT 16:20·       Dosing (1/2 Life) 18:25·       Storage 22:15Questions and comments to  [email protected]